logo

Quick Facts

Share

Austrian sensor manufacturer ams AG announced Monday that it has received unconditional regulatory approval from the EU commission for the acquisition of German lighting company Osram Licht AG (OSAGF.PK). The EU regulatory approval constituted the last remaining condition precedent for closing the...

ViacomCBS (VIACA, VIAC) and DISH Network Corp. (DISH) said that they have renewed their carriage agreement to continue delivering ViacomCBS's portfolio of broadcast, entertainment, news and sports networks to DISH and SLING TV customers. Terms of the agreement were not disclosed.

SINA Corp. (SINA) said its Board has received a preliminary non-binding proposal letter from New Wave MMXV Limited, proposing to acquire all the outstanding ordinary shares of SINA not already owned by New Wave for $41 per share in cash in a going private transaction. The Board of SINA Corp. has formed...

ANI Pharmaceuticals Inc. (ANIP) said that it has acquired Fluconazole Tablets USP, 50mg, 100mg, 150mg, and 200mg from a private company for $3.0 million. The current annual U.S. market for the product is approximately $40 million, according to IQVIA/IMS Health. Fluconazole Tablets USP is indicated...

Uber Technologies, Inc. (UBER) and Postmates Inc. have reached a definitive deal, under which Uber will acquire Postmates for approximately $2.65 billion in an all-stock transaction. Uber currently estimates that it will issue approximately 84 million shares of common stock for 100% of the fully diluted...

Freeport-McMoRan Inc. (FCX) on Monday provided an update on its second-quarter operational and financial performance as well as its ongoing response to the COVID-19 pandemic. Assuming an average estimated second-quarter 2020 copper price realization of $2.54 per pound and preliminary sales estimates,...

BELLUS Health Inc. (BLU), a clinical-stage biopharmaceutical company, announced Monday that its Phase 2 RELIEF trial of BLU-5937 in patients with refractory chronic cough failed to achieve statistical significance for the primary endpoint. In pre-market activity on Nasdaq, BELLUS shares were trading...

ADC Therapeutics SA (ADCT) said Monday that the U.S. Food and Drug Administration has lifted the partial clinical hold on the pivotal Phase 2 clinical trial of camidanlumab tesirine (Cami, formerly ADCT-301) in patients with relapsed or refractory Hodgkin lymphoma or HL. The 100-patient Phase 2, multi-center,...

Abbott (ABT) announced that the U.S. FDA has approved the company's next-generation Gallant implantable cardioverter defibrillator or ICD and cardiac resynchronization therapy defibrillator or CRT-D devices. The company noted that the devices bring new benefits to patients with heart rhythm disorders,...

Merck (MRK) reported new analyses from the phase 2b trial evaluating the safety and efficacy of islatravir, in combination with doravirine, in adults with HIV-1 infection who had not previously received antiretroviral treatment. The company said these week 48 analyses reinforce the potential for islatravir...

Molecular diagnostics company Myriad Genetics, Inc. (MYGN) announced Monday a new collaboration with AI platform OptraHEALTH to implement a cognitive ChatBOT named Gene to provide pre-test genetic and financial assistance information to prospective patients. Gene is an AI-powered, HIPAA-compliant...

Dow Inc. (DOW) has agreed to sell its rail infrastructure assets and related equipment at six major North American sites to Watco Companies. The company anticipates to receive cash proceeds in excess of $310 million as part of the deal. Dow noted that it continues to evaluate the company's ownership...

Biotechnology company Regeneron Pharmaceuticals, Inc. (REGN) announced Monday the initiation of late-stage clinical trials evaluating REGN-COV2, Regeneron's investigational double antibody cocktail for the treatment and prevention of COVID-19. A Phase 3 trial will evaluate REGN-COV2's ability to...

STAAR Surgical Co. (STAA), a manufacturer of implantable lenses and companion delivery systems for the eye, announced Monday that Patrick Williams has joined as Chief Financial Officer with immediate effect. Williams succeeds Deborah Andrews, who announced her retirement plan in December last year....

Emergent BioSolutions Inc. (EBS) has reached a five-year manufacturing services agreement for large-scale drug substance manufacturing for Johnson & Johnson's investigational SARS-CoV-2 vaccine, Ad26.COV2-S. Emergent will provide contract development and manufacturing services to produce drug substance...

Follow RTT